These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 17418832

  • 1. Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.
    De Leo V, Morgante G, Piomboni P, Musacchio MC, Petraglia F, Cianci A.
    Fertil Steril; 2007 Jul; 88(1):113-7. PubMed ID: 17418832
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
    Batukan C, Muderris II.
    Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
    [Abstract] [Full Text] [Related]

  • 3. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A, De Leo V.
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome.
    Pehlivanov B, Mitkov M.
    Eur J Contracept Reprod Health Care; 2007 Mar; 12(1):30-5. PubMed ID: 17455042
    [Abstract] [Full Text] [Related]

  • 5. The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome.
    Sağsöz N, Orbak Z, Noyan V, Yücel A, Uçar B, Yildiz L.
    Fertil Steril; 2009 Aug; 92(2):660-6. PubMed ID: 18973889
    [Abstract] [Full Text] [Related]

  • 6. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
    De Leo V, Di Sabatino A, Musacchio MC, Morgante G, Scolaro V, Cianci A, Petraglia F.
    Contraception; 2010 Sep; 82(3):276-80. PubMed ID: 20705157
    [Abstract] [Full Text] [Related]

  • 7. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
    Panidis D, Georgopoulos NA, Piouka A, Katsikis I, Saltamavros AD, Decavalas G, Diamanti-Kandarakis E.
    Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
    [Abstract] [Full Text] [Related]

  • 8. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
    Kriplani A, Periyasamy AJ, Agarwal N, Kulshrestha V, Kumar A, Ammini AC.
    Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
    [Abstract] [Full Text] [Related]

  • 9. Determining the time androgens and sex hormone-binding globulin take to return to baseline after discontinuation of oral contraceptives in women with polycystic ovary syndrome: a prospective study.
    Sánchez LA, Pérez M, Centeno I, David M, Kahi D, Gutierrez E.
    Fertil Steril; 2007 Mar; 87(3):712-4. PubMed ID: 17118366
    [Abstract] [Full Text] [Related]

  • 10. SHBG, testosterone, androstenedione, 17-OH-Progesterone plasma levels in PCO affected women treated with a triphasic oral contraceptive.
    Negri P, Agnello G, Borghesani F, Tomain L, Minisci N, D'Errico G, Cavallini AR.
    Acta Eur Fertil; 1987 Mar; 18(6):375-80. PubMed ID: 3454501
    [Abstract] [Full Text] [Related]

  • 11. Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.
    Romualdi D, Giuliani M, Draisci G, Costantini B, Cristello F, Lanzone A, Guido M.
    Fertil Steril; 2007 Jul; 88(1):131-8. PubMed ID: 17336978
    [Abstract] [Full Text] [Related]

  • 12. Treatment of hirsutism with combined pill containing drospirenone.
    Gregoriou O, Papadias K, Konidaris S, Bakalianou K, Salakos N, Vrachnis N, Creatsas G.
    Gynecol Endocrinol; 2008 Apr; 24(4):220-3. PubMed ID: 18382909
    [Abstract] [Full Text] [Related]

  • 13. Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers.
    Oelkers W, Helmerhorst FM, Wuttke W, Heithecker R.
    Gynecol Endocrinol; 2000 Jun; 14(3):204-13. PubMed ID: 10923282
    [Abstract] [Full Text] [Related]

  • 14. Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone.
    Oelkers W.
    Eur J Contracept Reprod Health Care; 2000 Dec; 5 Suppl 3():17-24. PubMed ID: 11246598
    [Abstract] [Full Text] [Related]

  • 15. A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism.
    Oner G, Muderris II.
    Contraception; 2011 Nov; 84(5):508-11. PubMed ID: 22018126
    [Abstract] [Full Text] [Related]

  • 16. Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome.
    Uras R, Orrù M, Pani F, Marotto MF, Pilloni M, Guerriero S, Etzi R, Zedda P, Sorge R, Lello S, Melis GB, Paoletti AM.
    Contraception; 2010 Aug; 82(2):131-8. PubMed ID: 20654753
    [Abstract] [Full Text] [Related]

  • 17. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Seeger JD, Loughlin J, Eng PM, Clifford CR, Cutone J, Walker AM.
    Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
    [Abstract] [Full Text] [Related]

  • 18. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
    Lello S, Primavera G, Colonna L, Vittori G, Guardianelli F, Sorge R, Raskovic D.
    Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
    [Abstract] [Full Text] [Related]

  • 19. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
    Bhattacharya SM, Jha A.
    Fertil Steril; 2012 Oct; 98(4):1053-9. PubMed ID: 22795636
    [Abstract] [Full Text] [Related]

  • 20. YAZ and the novel progestin drospirenone.
    Mishell DR.
    J Reprod Med; 2008 Sep; 53(9 Suppl):721-8. PubMed ID: 18980044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.